Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you think you may have accidentally injected Wegovy into a vein rather than the skin, the most important thing to know is this: subcutaneous injections of semaglutide delivered into a vein by mistake are extremely unlikely with a correctly used pre-filled pen, and there is no published clinical evidence of serious harm from this specific error occurring during normal self-injection. That said, any injection-related concern deserves a calm, clear-headed response — so here is what the guidance and clinical data actually say, and when to seek help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy SmPC, published on the electronic Medicines Compendium, specifies subcutaneous injection into the abdomen, thigh, or upper arm. The pre-filled pen uses a short, fixed needle designed to reach the subcutaneous fat layer, the layer sitting between skin and muscle. Veins large enough to be entered accidentally sit deeper than that in the typical injection sites, which is why the needle length and body site combination makes true intravenous injection during routine self-administration physiologically very uncommon.
Subcutaneous fat at these sites is relatively avascular at the surface level. That does not mean a small, fine superficial vessel cannot be nicked (it can) but nicking a capillary is very different from depositing a full dose into a vein. Clinical pharmacokinetic studies included in the Wegovy regulatory submissions did not identify accidental venous injection as a notable event during home self-injection.
One misconception worth gently setting aside: seeing a small amount of blood in the needle or at the injection site does not confirm that the dose went into the bloodstream. Blood can appear when a tiny surface vessel is disturbed without any drug entering the vascular system. If you see a spot of blood after withdrawing the pen, apply light pressure with a clean cloth or swab, that is generally all that is needed.
For detailed guidance on correct injection sites and technique, the NHS patient information page for semaglutide is a practical starting point alongside the leaflet that comes with your pen.
The absence of published serious-harm cases from this specific scenario does not mean every post-injection concern should be dismissed. There are signs that justify calling 111 or going to an urgent treatment centre promptly.
Watch for sudden flushing or warmth spreading through the body immediately after the injection; a rapid or irregular heartbeat; dizziness or light-headedness; difficulty breathing; or swelling and severe pain at the injection site. These could indicate either a vascular event or an allergic reaction, both need professional assessment. Anaphylaxis is rare but listed in the Wegovy SmPC as a possible reaction; if you notice swelling of the face, lips or throat, call 999.
More commonly, people feel a brief sting or notice a small bruise, neither of which requires escalation. Mild nausea shortly after the injection is also a documented GI side effect of semaglutide itself rather than evidence of the dose entering a vein, and if you have also used a pen that was past its date, our page on what to do if you accidentally took expired semaglutide can help you work out whether that is a separate concern. The MHRA Yellow Card scheme allows patients to report any suspected side effect or unusual injection-related event, and doing so helps build the safety evidence base for everyone using these medicines.
Concerns about what is normal and what is not are among the questions our clinical team at nume fields regularly. If something felt wrong during or immediately after your injection, contact your prescriber the same day rather than waiting for your next scheduled review.
The Wegovy pen is designed to make correct technique straightforward, but small habits matter. Pinching a fold of skin before pressing the pen firmly against the site helps ensure the needle enters the subcutaneous layer rather than going too shallow (intradermal) or too deep. Injecting at a 90-degree angle to the skin surface is the standard approach for the pre-filled autoinjector pen. Rotating sites (abdomen one week, thigh the next) reduces localised tissue changes over time.
Avoid injecting into areas where you can feel a firm cord or pulsation beneath the surface, or where there is visible bruising or active inflammation. If you are unsure which site to use, the guidance on accidentally injecting semaglutide into muscle covers site anatomy in practical terms and is worth reading alongside this page.
A question about storage is also common at this stage: if the injection experience raised doubts about whether the pen had been stored correctly, our overview of what happens when Wegovy is left out of the fridge addresses that separately. And if you are newer to Wegovy and want to revisit how often and where the injection goes, the guide on injection frequency provides the factual background.
For anyone who felt the pen may have gone in at the wrong depth, our pages on what happens if you accidentally inject Wegovy into muscle and on having injected Wegovy into muscle walk through what that means practically and what to watch for afterwards. For anyone considering Wegovy as part of a clinically supervised programme, a free consultation with a nume prescriber is the place to start, injection technique, eligibility and your full medical history are all reviewed before treatment begins. Check your eligibility and speak to a real clinician, not a questionnaire.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.